Acadia Healthcare (NASDAQ:ACHC) Upgraded to “Hold” by Deutsche Bank Aktiengesellschaft

Acadia Healthcare (NASDAQ:ACHC) was upgraded by Deutsche Bank Aktiengesellschaft from a “sell” rating to a “hold” rating in a research note issued on Thursday, Marketbeat reports. The brokerage presently has a $70.00 target price on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential downside of 4.88% from the stock’s previous close.

ACHC has been the subject of a number of other research reports. UBS Group lifted their target price on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. Mizuho boosted their price target on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, March 6th. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, Stephens raised Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a report on Friday, January 5th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $92.00.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock opened at $73.59 on Thursday. The stock’s fifty day moving average price is $78.07 and its 200-day moving average price is $77.66. Acadia Healthcare has a 12 month low of $66.49 and a 12 month high of $87.77. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm has a market cap of $6.80 billion, a P/E ratio of -294.35, a P/E/G ratio of 2.10 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. During the same quarter in the previous year, the firm earned $0.70 earnings per share. The company’s revenue was up 10.0% on a year-over-year basis. On average, equities research analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 2.80% of the company’s stock.

Institutional Trading of Acadia Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. GAMMA Investing LLC acquired a new stake in shares of Acadia Healthcare in the 4th quarter valued at approximately $26,000. Headlands Technologies LLC acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at approximately $25,000. Mather Group LLC. acquired a new position in Acadia Healthcare during the first quarter worth $48,000. Fifth Third Bancorp raised its holdings in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare during the third quarter worth $96,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.